Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Crinetics Pharmaceuticals, Inc. (CRNX) had Free Cash Flow per Share of $-4.08 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$7.70M |
|
$-465.32M |
|
$1.08M |
|
$6.62M |
|
$524.47M |
|
$-516.77M |
|
$51.63M |
|
$-465.14M |
|
$-465.14M |
|
$-465.32M |
|
$-465.32M |
|
$-465.32M |
|
$-465.32M |
|
$-516.77M |
|
$-528.30M |
|
94.06M |
|
94.06M |
|
$-4.95 |
|
$-4.95 |
|
| Balance Sheet Financials | |
$1.05B |
|
$14.30M |
|
$77.92M |
|
$1.13B |
|
$85.07M |
|
-- |
|
$49.10M |
|
$134.17M |
|
$992.08M |
|
$992.08M |
|
$992.08M |
|
95.58M |
|
| Cash Flow Statement Financials | |
$-377.92M |
|
$173.91M |
|
$40.61M |
|
$265.85M |
|
$102.34M |
|
$-163.51M |
|
$91.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.32 |
|
-- |
|
-- |
|
-- |
|
-- |
|
86.02% |
|
-6714.77% |
|
-6714.77% |
|
-6864.66% |
|
-6043.88% |
|
-6046.22% |
|
$-383.68M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
0.53 |
|
13.00 |
|
28.08 |
|
-46.90% |
|
-46.90% |
|
-41.32% |
|
-46.90% |
|
$10.38 |
|
|
Free Cash Flow per Share |
$-4.08 |
$-4.02 |
|